CUP Analyst Ratings
Moderate Buy
7 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CUP Stock 12 Month Forecast
Average Price Target
€51.68
▲(31.53% Upside)
| Highest Price Target€72.47 | Average Price Target€51.68 | Lowest Price Target€42.94 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
€45.63→€42.94
Hold
9.30%
Upside
Reiterated
07/26/26
Bernstein
€52.61
Buy
33.89%
Upside
Reiterated
07/07/26
Goldman Sachs
€48.04
Buy
22.28%
Upside
Upgraded
06/15/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
€45.63→€42.94
Hold
9.30%
Upside
Reiterated
07/26/26
Bernstein
€52.61
Buy
33.89%
Upside
Reiterated
07/07/26
Goldman Sachs
€48.04
Buy
22.28%
Upside
Upgraded
06/15/26
Best Analysts Covering Chugai Pharmaceutical Co
3 Months
Success Rate
4/6 ratings generated profit
Average Return
+9.65%
Copying Seiji Wakao's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.65% per trade.
1 Year
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CUP Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
1
1
1
0
Buy
13
11
8
4
6
Hold
1
6
9
9
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
18
18
14
11
Each month's total comprises the sum of three months' worth of ratings.
CUP Financial Forecast
CUP Stock Forecast FAQ
What is DE:CUP’s average 12-month price target, according to analysts?
Based on analyst ratings, Chugai Pharmaceutical Co Ltd’s 12-month average price target is 51.68.
What is DE:CUP’s upside potential, based on the analysts’ average price target?
Chugai Pharmaceutical Co Ltd has 31.53% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Chugai Pharmaceutical Co Ltd a Buy, Sell or Hold?
Chugai Pharmaceutical Co Ltd has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 0 sell ratings.
What is Chugai Pharmaceutical Co Ltd’s share price target?
The average share price target for Chugai Pharmaceutical Co Ltd is 51.68. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €72.47 ,and the lowest forecast is €42.94. The average share price target represents 31.53% Increase from the current price of €39.29.
The highest analyst share price target is €72.47 ,and the lowest forecast is €42.94. The average share price target represents 31.53% Increase from the current price of €39.29.
What do analysts say about Chugai Pharmaceutical Co Ltd?
Chugai Pharmaceutical Co Ltd’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of Chugai Pharmaceutical Co Ltd?
To buy shares of DE:CUP, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.